Puriblood Medical Co., Ltd. (TPEX:6847)
Taiwan · Delayed Price · Currency is TWD 88.70
+0.60 (0.68%)
Jun 3, 2026, 1:52 PM CST
Puriblood Medical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -39 | -5.37 | -51.6 | 16.53 | -38.02 |
Depreciation & Amortization | 7.8 | 8.17 | 7.99 | 7.68 | 6.27 |
Other Amortization | - | 0.12 | 0.11 | 0.09 | 0.16 |
Loss (Gain) From Sale of Assets | - | 0.02 | - | 0.15 | - |
Loss (Gain) From Sale of Investments | 4.75 | 7.03 | 3.75 | -10.05 | 1.9 |
Loss (Gain) on Equity Investments | 6.09 | 1.06 | 0.96 | 0.13 | 0.07 |
Stock-Based Compensation | 0.69 | - | - | - | 0.09 |
Other Operating Activities | -10.13 | -23.23 | -2.96 | 0.4 | 2.03 |
Change in Accounts Receivable | -15.74 | -6.32 | 10.07 | -10.33 | 7.13 |
Change in Inventory | 3.35 | -5.72 | 6.62 | -13.51 | -11.96 |
Change in Accounts Payable | 19.84 | -7.12 | 11.27 | 2.06 | 1.17 |
Change in Unearned Revenue | -0.35 | 0.26 | -7.88 | 7.41 | -0.02 |
Change in Other Net Operating Assets | -4.69 | 1.42 | 48.33 | -31.4 | -12.5 |
Operating Cash Flow | -27.39 | -29.68 | 26.65 | -30.83 | -43.68 |
Capital Expenditures | - | -2.06 | -6.25 | -2.21 | -3.15 |
Sale of Property, Plant & Equipment | - | 0.67 | - | 0.12 | - |
Sale (Purchase) of Intangibles | - | - | -0.1 | -9.25 | -1.95 |
Sale (Purchase) of Real Estate | -0.48 | - | - | - | - |
Investment in Securities | 2.5 | - | 3 | -13.5 | -20 |
Other Investing Activities | -0.01 | -0.01 | 0.1 | -0.8 | 0.74 |
Investing Cash Flow | 2.01 | -1.4 | -3.25 | -25.64 | -24.35 |
Short-Term Debt Issued | 5 | - | - | - | - |
Long-Term Debt Issued | - | 20 | 28.21 | 30 | - |
Total Debt Issued | 5 | 20 | 28.21 | 30 | - |
Long-Term Debt Repaid | -5.8 | -19.8 | -33.18 | -3.66 | -3.59 |
Total Debt Repaid | -5.8 | -19.8 | -33.18 | -3.66 | -3.59 |
Net Debt Issued (Repaid) | -0.8 | 0.2 | -4.97 | 26.34 | -3.59 |
Issuance of Common Stock | - | - | - | - | 108.3 |
Other Financing Activities | - | - | -0.44 | -2.24 | -4.65 |
Financing Cash Flow | -0.8 | 0.2 | -5.42 | 24.1 | 100.06 |
Net Cash Flow | -26.18 | -30.87 | 17.98 | -32.37 | 32.03 |
Free Cash Flow | -27.39 | -31.74 | 20.4 | -33.04 | -46.83 |
Free Cash Flow Margin | -33.27% | -28.68% | 16.28% | -24.04% | -85.78% |
Free Cash Flow Per Share | -1.92 | -2.23 | 1.43 | -2.32 | -4.02 |
Cash Interest Paid | - | 0.81 | 1.35 | 1.32 | 0.87 |
Cash Income Tax Paid | - | 0.08 | 0.09 | 0.01 | - |
Levered Free Cash Flow | -11.89 | -11.75 | 37.16 | -48.33 | -36.87 |
Unlevered Free Cash Flow | -11.22 | -11.25 | 37.97 | -47.66 | -36.44 |
Change in Working Capital | 2.41 | -17.49 | 68.4 | -45.76 | -16.17 |